Alzinova
Alzinova presents at Redeye Investor AW - Gothenburg
Alzinova AB (publ) (“Alzinova” or the “Company”) will present today, December 15, at Redeye Investor AW in Gothenburg, the presentation is held at 19.05. Alzinovas CEO Kristina Torfgård will present the Company's business and provide an update on the ongoing Phase 1b study of the vaccine candidate ALZ-101 against Alzheimer's disease.
CEO Kristina Torfgård will present Alzinova and provide an update on the Company's vaccine candidate for Alzheimer's disease, ALZ-101, and the ongoing Phase 1b study at the live Redeye Investor AW event in Gothenburg on December 15 at 7:05 p.m. The live broadcast of the event can be viewed on Redeye's website at: https://www.redeye.se/events/850217/investor-aw-goteborg-5
Datum | 2022-12-15, kl 08:00 |
Källa | MFN |
